Teaching medication compliance to psychiatric residents: Placing an orphan topic into a training curriculum

Academic Psychiatry

Volumn 29, Issue 2, 2005, Pages 203-210

  Weiden, Peter J ^a   Rao, Nyapati ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AWARENESS; CURRICULUM; PATIENT COMPLIANCE; PSYCHIATRIST; PSYCHOPHARMACOLOGY; PSYCHOTHERAPY; RESIDENCY EDUCATION; RESIDENT; REVIEW; ARTICLE; DOCTOR PATIENT RELATION; EDUCATION; HUMAN; MEDICAL EDUCATION;

CURRICULUM; HUMANS; INTERNSHIP AND RESIDENCY; PATIENT COMPLIANCE; PHYSICIAN-PATIENT RELATIONS; PSYCHOPHARMACOLOGY; PSYCHOTHERAPY;

EID: 26944447579     PISSN: 10429670     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ap.29.2.203     Document Type: Review

References (45)

1. Horwitz RI, Horwitz SM: Adherence to treatment and health outcomes. Archives of Internal Med 1993; 153:1863-1868
2. Lerner BH, Gulick RM, Dubler NN: Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease. Annals of Internal Med 1998; 129:573-578
3. Johnson DAW: Further observations on the duration of depot neuroleptic maintenance therapy in schizophrenia. Br J Psychiatry 1979; 135:524-530
4. Pampallona S, Bollini P, Tibaldi G, et al: Patient adherence in the treatment of depression. Br J Psychiatry 2002; 180:104-109
5. Sajatovic M, Davies M, Hrouda DR: Enhancement of treatment adherence among patients with bipolar disorder. Psychiatr Serv 2004; 55:264-269
6. Weiden P, Olfson M. Cost of relapse in schizophrenia. Schizophrenia Bulletin 1995; 21:419-428
7. Weiden P: Psychopharmacologic management of noncompliance in schizophrenia. J Practical Psychiatry and Behavioral Health 1997; 3:239-245
8. Zygmunt A, Olfson M, Boyer CA, et al: Interventions to improve medication adherence in schizophrenia. Am J Psychiatry 2002; 159:1653-1664
9. Velligan DI, Prihoda TJ, Ritch JL, et al: A randomized single-blind pilot study of compensatory strategies in schizophrenia outpatients. Schizophrenia Bulletin 2002; 28:283-292
10. Neurology ABoP. Psychiatry and Neurology Core Competencies Version 4.1; 2004
11. Haynes RB, Taylor DW, Sackett DL: Compliance in health care. Baltimore: Johns Hopkins University Press; 1979
12. Weiden PJ, Kozma C, Grogg A, et al: The relationship between medication compliance and hospitalization in patients with schizophrenia: a retrospective review of the California medicaid database. Psychiatr Services 2004; 55:886-891
13. Cramer J, Mattson R, Prevey M, et al: How often is medication taken as prescribed? A novel assessment technique. JAMA 1989; 261:3273-3277
14. Schooler NR, Levine J, Severe JB, et al: Prevention of relapse in schizophrenia: An evaluation of fluphenazine decanoate. Archives of General Psychiatry 1980; 37:16-24
15. Norell SE: Accuracy of patient interviews and estimates of clinical staff in determining medication compliance. Soc Science and Med 1981; 15:57
16. Barofsky I: Compliance, adherence, and the therapeutic alliance: steps in the development of self-care. Soc Science and Med 1978; 12:369-376
17. Grunebaum MF, Weiden PJ, Olfson M: Medication supervision and adherence of persons with psychotic disorders in residential treatment settings: A pilot study. J Clin Psychiatry 2001; 62:394-399
18. Blackwell Scientific B: Treatment adherence. Am J Psychiatry 1976; 129:513-531
19. Perkins DO: Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry 2002; 63:1121-118
20. Fenton W, Blyler C, Heinssen R. Determinants of medication compliance in schizophrenia: Empirical and clinical findings. Schizophrenia Bulletin 1997; 23:637-651
21. Frank AF, Gunderson JG: The role of the therapeutic alliance in the treatment of schizophrenia. Archives of General Psychiatry 1990; 47:228-235
22. Jamison KR, Akiskal HS: Medication compliance in patients with bipolar disorder, pcna 1983; 6:175-192
23. Jamison K. Lithium compliance in manic-depressive illness. In: Blackwell Scientific B, Ed. Treatment compliance and the therapeutic alliance. 5 vol. Amsterdam: Harwood Academic Press Publishers; 1996:251-275
24. Tuma A, May P, Yale C, et al: Therapist characteristics and outcome of treatment of schizophrenia. Archives of General Psychiatry 1978; 35:81-85
25. Corrigan PW, Liberman RP, Engel JD: From noncompliance to collaboration in the treatment of schizophrenia. Hosp and Community Psychiatry 1990; 41:1203-1211
26. Blaska B: The myriad medication mistakes in psychiatry: A consumer's view. Hosp and Community Psychiatry 1990; 41:993-998
27. Blackwell Scientific B, Griffin B, Magill M: Teaching medical students about treatment compliance. J Med Education 1978; 53:672
28. Rao NR, Meinzer AE, Berman SS: Countertransference: Its continued importance in psychiatric education. J Psychotherapy Practice and Res 1997; 6:1-11
29. Soumerai S, McLaughlin TJ, Ross-Degnan D, et al: Effects of limiting medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. New England J Med 1994; 331:650-655
30. Goldfinger SM, Hopkin JT, Surber RW: Treatment resisters or system resisters?: toward a better service system for acute care recidivists. New Directions in Ment Health Services 1984; 21:17-27
31. Eisenthal S, Emery R, Lazare A, et al: Adherance and the negotiated approach to patienthood. Archives of General Psychiatry 1979; 36:393-398
32. Hall JA, Dornan MC: What patients like about their medical care and how often they are asked: A meta-analysis of the satisfaction literature. Soc Science and Med 1988; 27:935-939
33. Moran AE, Freedman RI, Sharfstein SS: The journey of sylvia frumpkin: A case study for policy makers. Hosp and Community Psychiatry 1984; 35:887-893
34. Palardy N, Greening L, Ott J, et al: Adolescents' health attitudes and adherence to treatment for insulin-dependent diabetes mellitus. Developmental and Behavioral Pediatrics 1998; 19:31-37
35. Williams GC, Ryan RM, Rodin GC, et al: Autonomous regulation and long-term medication adherence in adult outpatients. Health Psychol 1998; 17:269-276
36. Fishbein M, Ajzen I. Belief, Attitude, Intention and Behavior. Reading,Mass; 1975
37. Becker MH: Patient adherence to prescribed therapies. Med Care 1985; 23:539-555
38. Becker MH, Maiman LA. Strategies for enhancing patient compliance. J Community Health 1980; 6:113-135
39. Haynes RB, Sackett DL, Taylor DW How to detect and manage low patient compliance in chronic illness. Geriatrics 1980; 35:91-93, 96-97
40. Haynes RB, Sackett DL, Gibson ES, et al: Improvement of medication compliance in uncontrolled hypertension. Lancet 1976; 1:1265-1268
41. Haynes RB, Sackett DL, Taylor DW, et al: Manipulation of the therapeutic regimen to improve compliance: conceptions and misconceptions. Clin Pharmacol Ther 1977; 22:125-130
42. Weiden PJ, Rapkin B, Mott T, et al: Rating of medication influences (ROMI) scale in schizophrenia. Schizophrenia Bulletin 1994; 20:297-310
43. Weiden PJ: Understanding depot therapy in schizophrenia. J Practical Psychiatry and Behavioral Health 1995; 1:182-184
44. Weiden P, Mackell J, MacDonell D. Obesity as a risk factor for antipsychotic noncompliance. Schizophrenia Research 2003:in press.
45. Viguera AC, Baldessarini RJ, Hegarty JD, et al: Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. Archives of General Psychiatry 1997; 54